• August 22, 2017 - Curtana Pharmaceuticals Successfully Completes Pre-IND Submission for CT-179 for the Treatment of Malignant Gliomas

    Download news release

  • August 15, 2017 - Curtana Pharmaceuticals Granted FDA Orphan Drug Designation for CT-179 for the Treatment of Gliomas

    Download news release

  • September 7, 2016 - Curtana Pharmaceuticals Selected to Present at Inaugural University Startups Demo Day in Washington, DC

    Download news release

  • June 1, 2016 - Curtana Pharmaceuticals Receives Top Honors at the 5th Annual Texas Life Science Forum

    Download news release

  • Nov. 18, 2015 - Gary W. Pace Joins Curtana Pharmaceuticals Board of Directors

    Download news release

  • Sept. 1, 2015 - Martin Simonetti Joins Curtana Board of Directors

    Download news release

  • Oct. 1, 2014 - Curtana Pharmaceuticals Awarded NIH Small Business Technology Transfer Grant To Advance Glioblastoma Therapy

    Download news release

  • Aug. 21, 2014 - Curtana Pharmaceuticals Awarded $7.6 Million Grant From The Cancer Prevention And Research Institute Of Texas

    Download news release

  • Nov. 27, 2013 - Curtana Adds Industry Luminaries to Scientific Advisory Board

    Download news release

  • Sept. 24, 2013 - Curtana Signs Exclusive Worldwide License Agreement

    Download news release